The Treatment of Older Patients With Multiple Myeloma
C. Ola Landgren, MD, PhD, a senior investigator in the Multiple Myeloma Section of the National Cancer Institute, discusses the treatment of older patients (over age 70) with multiple myeloma.
C. Ola Landgren, MD, PhD, a senior investigator in the Multiple Myeloma Section of the National Cancer Institute, discusses the treatment of older patients (over age 70) with multiple myeloma. This interview took place at the 2013 American Society of Hematology (ASH) Meeting.
Clinical Pearls
-Every year in the U.S., 10,000 people under the age of 70 and 10,000 people over the age of 70 are diagnosed with multiple myeloma
-Younger patients typically experience better outcomes while older patients do not see much improvement
@TargetedOncUsing newer therapy strategies, my projection is that#MultipleMyelomapts 70+ yrs will have 2-3x better survival within 5 yrs
Ola Landgren, M.D. (@DrOlaLandgren)April 9, 2014
-Now that older patients are being treated with new drugs, they​ are seeing an improvement in survival
Real-World RRMM Data Explore Dose Deescalation and Outpatient Use of Teclistamab
November 18th 2024During a Case-Based Roundtable® event, Hana Safah, MD, examined several real-world studies of dose frequency and outpatient administration of teclistamab in patients with multiple myeloma in the first article of a 2-part series.
Read More
